21-2096-1-QIAGEN_V1

• Research type

  Research Study

• Full title

  21-2096-1-QIAGEN

• IRAS ID

  304838

• Contact name

  Mike Burgess

• Contact email

  mike.burgess@qiagen.com

• Sponsor organisation

  QIAGEN

• Duration of Study in the UK

  2 years, 0 months, 1 days

• Research summary

  The intent of the study is to profiling samples with the QIAGEN IFIGx kit to enhance the understanding of type I interferon signature status with clinical phenotype. This involves testing of samples banked and will not be linked to any treatment decisions.

• REC name

  Yorkshire & The Humber - Leeds West Research Ethics Committee

• REC reference

  21/YH/0309

• Date of REC Opinion

  14 Jan 2022

• REC opinion

  Further Information Favourable Opinion